1. Home
  2. MAIA vs AMPG Comparison

MAIA vs AMPG Comparison

Compare MAIA & AMPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

SELL

Current Price

$1.01

Market Cap

69.2M

Sector

Health Care

ML Signal

SELL

Logo Amplitech Group Inc.

AMPG

Amplitech Group Inc.

HOLD

Current Price

$2.04

Market Cap

82.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAIA
AMPG
Founded
2018
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
69.2M
82.0M
IPO Year
2022
2012

Fundamental Metrics

Financial Performance
Metric
MAIA
AMPG
Price
$1.01
$2.04
Analyst Decision
Analyst Count
0
0
Target Price
★ $12.00
N/A
AVG Volume (30 Days)
246.6K
★ 676.3K
Earning Date
11-09-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
★ 69.44
EPS
N/A
★ N/A
Revenue
N/A
★ $25,195,930.00
Revenue This Year
N/A
$44.47
Revenue Next Year
N/A
$64.84
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 164.99
52 Week Low
$0.87
$1.64
52 Week High
$3.19
$10.11

Technical Indicators

Market Signals
Indicator
MAIA
AMPG
Relative Strength Index (RSI) 38.89 30.80
Support Level N/A $1.75
Resistance Level $1.48 $2.18
Average True Range (ATR) 0.06 0.19
MACD -0.00 -0.01
Stochastic Oscillator 23.11 5.18

Price Performance

Historical Comparison
MAIA
AMPG

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.

About AMPG Amplitech Group Inc.

AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. It operates in two segments: the manufacturing and engineering segment. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.

Share on Social Networks: